Latest Insider Transactions at Aim Immuno Tech Inc. (AIM)
This section provides a real-time view of insider transactions for Aim Immuno Tech Inc. (AIM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AIM ImmunoTech Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AIM ImmunoTech Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 16
2021
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
15,625
+6.49%
|
$15,625
$1.92 P/Share
|
|
Feb 25
2021
|
Stewart Appelrouth Director |
BUY
Open market or private purchase
|
Direct |
10,638
+10.31%
|
$21,276
$2.35 P/Share
|
|
Feb 24
2021
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
11,062
+5.01%
|
$22,124
$2.26 P/Share
|
|
Dec 17
2020
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
14,535
+6.82%
|
$14,535
$1.72 P/Share
|